Chronic kidney disease. Chronic kidney disease (CKD)
Conditions
Interventions
Intervention group: IM injection of Testosterone enanthate 100, (each ampoule 1 ml contains Teastosterone Enanthate 100 mg) every 2 weeks for 3 months. Each patient recieves 6 injections..
Sponsors
Ardabil University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: GFR less than 45 BMI 25 to30 Male Gender Testestrone lower than 3.5 ng/lit
Exclusion criteria
Exclusion criteria: Any pituitery diseas Liver dysfunction Heart failure Any thyroid disease Using any fat depressors Prostate cancer Breast cancer BPH with obstruction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Cholestrol. Timepoint: First of study and 3 months later. Method of measurement: Lab test.;Serum Triglyceride. Timepoint: First of study and 3 months later. Method of measurement: Lab test.;LDL Cholestrol. Timepoint: First of study and 3 months later. Method of measurement: Lab test.;HDL Cholestrol. Timepoint: First of study and 3 months later. Method of measurement: Lab test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Testestrone. Timepoint: At the beginning of the study and three months later. Method of measurement: Lab test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Kameli
Ardabil University of Medical Sciences
Outcome results
None listed